SPONSOR
Shanghai Huaota Biopharmaceutical Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 2
Shanghai Huaota Biopharmaceutical Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Advanced Solid Tumor, NSCLC, Generalized Pustular Psoriasis (GPP).
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Huaota Biopharmaceutical Co., Ltd.
How many clinical trials has Shanghai Huaota Biopharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shanghai Huaota Biopharmaceutical Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumor, NSCLC, Generalized Pustular Psoriasis (GPP). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Huaota Biopharmaceutical Co., Ltd. research focus on?
Shanghai Huaota Biopharmaceutical Co., Ltd. clinical trials span Advanced Solid Tumor, NSCLC, Generalized Pustular Psoriasis (GPP). The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Huaota Biopharmaceutical Co., Ltd. clinical trial?
To participate in a Shanghai Huaota Biopharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Huaota Biopharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai Huaota Biopharmaceutical Co., Ltd.
NCT05417321 Phase 1, Phase 2
Recruiting
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Advanced Solid Tumor
NCT06231381 Phase 2
Recruiting
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Generalized Pustular Psoriasis (GPP)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology